Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation.

Alpdogan SO, Lu SX, Patel N, McGoldrick S, Suh D, Budak-Alpdogan T, Smith OM, Grubin J, King C, Goldberg GL, Hubbard VM, Kochman AA, van den Brink MR.

Blood. 2008 Dec 1;112(12):4755-64. doi: 10.1182/blood-2008-02-142737. Epub 2008 Sep 24.

2.

Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.

Alpdogan O, Eng JM, Muriglan SJ, Willis LM, Hubbard VM, Tjoe KH, Terwey TH, Kochman A, van den Brink MR.

Blood. 2005 Jan 15;105(2):865-73. Epub 2004 Jul 27.

3.

The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.

Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB.

Biol Blood Marrow Transplant. 2002;8(11):588-96.

PMID:
12463477
4.

The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Na IK, Lu SX, Yim NL, Goldberg GL, Tsai J, Rao U, Smith OM, King CG, Suh D, Hirschhorn-Cymerman D, Palomba L, Penack O, Holland AM, Jenq RR, Ghosh A, Tran H, Merghoub T, Liu C, Sempowski GD, Ventevogel M, Beauchemin N, van den Brink MR.

J Clin Invest. 2010 Jan;120(1):343-56. doi: 10.1172/JCI39395. Epub 2009 Dec 1.

5.

Chronic GvHD decreases antiviral immune responses in allogeneic BMT.

Hossain MS, Roback JD, Pollack BP, Jaye DL, Langston A, Waller EK.

Blood. 2007 May 15;109(10):4548-56. Epub 2007 Feb 8.

6.
7.

Mouse embryonic stem cell-derived thymic epithelial cell progenitors enhance T-cell reconstitution after allogeneic bone marrow transplantation.

Lai L, Cui C, Jin J, Hao Z, Zheng Q, Ying M, Boyd R, Zhao Y.

Blood. 2011 Sep 22;118(12):3410-8. doi: 10.1182/blood-2011-03-340794. Epub 2011 Jul 26.

9.
12.

Fas-deficient lpr mice are more susceptible to graft-versus-host disease.

van Den Brink MR, Moore E, Horndasch KJ, Crawford JM, Hoffman J, Murphy GF, Burakoff SJ.

J Immunol. 2000 Jan 1;164(1):469-80.

13.

Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death.

Wekerle T, Kurtz J, Sayegh M, Ito H, Wells A, Bensinger S, Shaffer J, Turka L, Sykes M.

J Immunol. 2001 Feb 15;166(4):2311-6.

14.

Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation.

Cooke KR, Krenger W, Hill G, Martin TR, Kobzik L, Brewer J, Simmons R, Crawford JM, van den Brink MR, Ferrara JL.

Blood. 1998 Oct 1;92(7):2571-80.

15.
16.

IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Alpdogan O, Muriglan SJ, Eng JM, Willis LM, Greenberg AS, Kappel BJ, van den Brink MR.

J Clin Invest. 2003 Oct;112(7):1095-107.

17.
18.

Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.

Lu SX, Kappel LW, Charbonneau-Allard AM, Atallah R, Holland AM, Turbide C, Hubbard VM, Rotolo JA, Smith M, Suh D, King C, Rao UK, Yim N, Bautista JL, Jenq RR, Penack O, Na IK, Liu C, Murphy G, Alpdogan O, Blumberg RS, Macian F, Holmes KV, Beauchemin N, van den Brink MR.

PLoS One. 2011;6(7):e21611. doi: 10.1371/journal.pone.0021611. Epub 2011 Jul 6.

19.
20.

CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT.

Johnson BD, Konkol MC, Truitt RL.

Biol Blood Marrow Transplant. 2002;8(10):525-35.

PMID:
12434947

Supplemental Content

Support Center